Catalent | Actif À Court Terme



Current Assets Changement Date
Agilent USD 4.21B 101M 2025-04
AstraZeneca USD 26.14B 312M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Bruker USD 2.11B 53.2M 2025-03
Centene USD 41.29B 3.29B 2025-03
Charles River Laboratories USD 1.51B 103.29M 2025-03
Cigna USD 43.56B 5.32B 2025-03
Danaher USD 9.52B 28M 2025-03
Dentsply International USD 1.98B 232M 2025-03
Elevance Health 58.73B 4.12B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Hologic USD 3.21B 284.9M 2025-03
Humana USD 29.82B 3.11B 2024-12
Illumina USD 2.67B 73M 2025-03
Intuitive Surgical USD 11.88B 331.3M 2025-03
IQVIA Holdings USD 5.91B 82M 2025-03
J&J USD 71.55B 15.66B 2025-03
Laboratory Of America USD 3.79B 1.02B 2025-03
Lonza CHF 5.44B 113M 2024-12
McKesson USD 55.4B 3.66B 2025-03
Merck EUR 12.41B 1.04B 2025-03
Merck USD 35.5B 3.28B 2025-03
Mettler Toledo International USD 1.16B 29.11M 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Quest Diagnostics USD 2.08B 317M 2025-03
Repligen USD 1.03B 33.58M 2025-03
Revvity USD 2.32B 31.67M 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Thermo Fisher Scientific USD 23.38B 1.24B 2025-03
UnitedHealth 85.78B 6.48B 2024-12
Waters USD 1.74B 70.77M 2025-03
West Pharmaceutical Services USD 1.46B 80.6M 2025-03



Catalent Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.